• Overarching Political Issues

CEO Update | 24 January 2022

I am looking forward to our first in-person events of 2022 this week, headlined by the BIA’s Annual Gala Dinner. This is a chance to celebrate the fantastic work undertaken by the sector throughout 2021 and raise money for our Charity Partner of the Year, Kidney Research UK. There are a few individual tickets left, so do book quickly if you are interested in attending.

A guide to the Government for BIA members - September 2021

Correct as of 15 September 2021. This is a briefing for BIA members on the Government led by Boris Johnson, and key ministerial appointments following the most recent reshuffle.

Dr John Brown, CBE to retire as Cell and Gene Therapy Catapult’s Chairman

John Brown will retire at the end of 2021 after nine years in the role. Dr John Brown, CBE, FRSE, Chairman of Cell and Gene Therapy Catapult (CGT Catapult), will retire from the role at the end of 2021 after completing three successive terms. The Nomination Committee will establish a process, led by Hilary Newiss, to identify and appoint his successor in due course.

Strong alignment between Gov’t Life Sciences Vision & Discovery Park strategy

Sandwich, Kent, July 12 2021 – There is strong complementarity between the UK Government’s new Life Sciences Vision1 and the strategy at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies.

Press Release: Over £100m cash boost to manufacture millions of doses of COVID-19 vaccine

- New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investment - Additional £4.7m for new training facilities and an online learning platform to boost vaccine as well as cell and gene therapy skills - New centre and skills vital for the UK’s ability respond to diseases like coronavirus, and potential future pandemics

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids

Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP) to support healthcare systems preparing for the Covid-19 pandemic.

CEO update | 1 July 2019

News from the BIA CEO, Steve Bates.... On Wednesday last week we got new guidance from the Government on no-deal Brexit preparedness with just 127 days to go until the Halloween deadline for the current extension period.

BIA warns there is little time to avoid disruption as government announces ‘no-deal’ Brexit planning

Steve Bates OBE, CEO of the BIA responds to the Written Ministerial Statement on EU Exit preparedness published by the Government today.

Guest blog | Sean Morgan-Jones | UK Biotech PLC is Totally Smashing It...

‘The UK is leading a two speed Europe’ (McKinsey & Company, Biotech in Europe: Scaling Innovation May 20, 2019). One of the key findings and contrary to the received wisdom, is that the UK is totally smashing it on all measures as a Biotech hot spot according to research presented at BioEquity Europe in Barcelona by McKinsey & Company looking at where's hot and where's not. Of the 1,000 European Biotechs established since 2012 the UK is leading by a country mile and represents 35% of all new Biotechs and according to the report and is leading a two speed Europe (with Germany, France and Spain in relative decline). 

CEO Update | Monday 17 June

Today, the BIA is pleased to publish a new report, ‘Life sciences: Catalysing investment and growth”. which sets out how our sector is driving investment and growth across the UK and makes the case for increased cost-effective public investment in the sector. The report aims to inform the Government, UKRI and other policy makers as they prepare for the forthcoming Spending Review and develop an R&D roadmap to reach 2.4% R&D target.